17-HYDROXYPROGESTERONE (17-OHP) - NEONATAL SCREENING - ANVISA Registration 80048490105

Access comprehensive regulatory information for 17-HYDROXYPROGESTERONE (17-OHP) - NEONATAL SCREENING in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 80048490105 and manufactured by MONOBIND, INC. The registration is held by USA DIAGNOSTICA LTDA with validity until May 12, 2035.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 3 companies making the same product including WALLAC OY, LABSYSTEMS DIAGNOSTICS OY, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.